|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Jul―08 |
COVID-19 vaccination prevents venous thrombosis in patients with SARS-CoV-2 infection and thereafter |
Giuseppe Lippi, Emmanuel J. Favaloro |
2 |
[GO] |
2024―Apr―16 |
Plasma tissue factor pathway inhibitor levels in coronavirus disease 2019 patients: a systematic review and meta-analysis |
Saeed Hassani, Mohammad Sayyadi, Amir Almasi-Hashiani |
3 |
[GO] |
2023―Oct―13 |
Diagnosis and treatment of coagulopathy using thromboelastography with platelet mapping is associated with decreased risk of pulmonary failure in COVID-19 patients |
Tjasa Hranjec, Mackenzie Mayhew, Bradley Rogers, Rachele Solomon, Deborah Hurst, Michael Estreicher, et al. (+10) Alberto Augusten, Aaron Nunez, Melissa Green, Shivali Malhotra, Randy Katz, Andrew Rosenthal, Sara Hennessy, Paul Pepe, Robert Sawyer, Juan Arenas |
4 |
[GO] |
2023―Sep―27 |
Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic |
Jennifer Davila, William B. Mitchell, Kerry Morrone, Ellen J. Silver, Caterina P. Minniti, Henny H. Billett, et al. (+3) Payal C. Desai, Sarah H. O’Brien, Deepa Manwani |
5 |
[GO] |
2023―Mar―27 |
The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection |
Haifa M. AlNafea, Aida A. Korish |
6 |
[GO] |
2023―Jan―31 |
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology |
Minoo Shahidi, Mohammad Reza Amirzargar |
7 |
[GO] |
2022―Sep―27 |
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations |
Burcu Altındağ Avcı, Mustafa Doğan, Bahadır Batar, İlker Yıldırım, Elif Serdal, Sümbül Gezer, et al. (+3) Çağatay L. Onar, Seval Akpınar, Burhan Turgut |
8 |
[GO] |
2022―Aug―10 |
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination |
Mona Al-Ahmad, Mona Al Rasheed, Lulwa Altourah, Tito Rodriguez-Bouza, Neveen Shalaby |
9 |
[GO] |
2022―Jul―14 |
Challenging treatment for refractory acquired haemophilia A complicated with severe severe acute respiratory coronavirus 2 infection |
Tamara Lado Cives, Marta Fernández Docampo, María Teresa Fernández Fernández, Diana Martínez Señarís, Alejandro Hevilla Carmona, Almudena Pérez-Rodríguez, et al. (+2) María del Carmen Gómez del Castillo Solano, María Fernanda López Fernández |
10 |
[GO] |
2022―Jun―15 |
Postacute elevation of D-dimer levels in severe acute respiratory syndrome coronavirus 2-positive nonhospitalized patients with mild symptoms |
Rebecca Folkman, Habiba Kamal, Marcus Ahl, Adrian Szum, Maria Magnusson, Soo Aleman |
11 |
[GO] |
2022―Mar―03 |
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients |
Fatma Demet Arslan, Banu İşbilen Başok, Mustafa Terzioğlu, Tuba Kansu Altan, Yeşer Karaca, Süheyla Serin Senger, Ayfer Çolak |
12 |
[GO] |
2022―Jan―04 |
Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination |
Reem H. Matar, Christian A. Than, Hayato Nakanishi, Rohan Suresh Daniel, Karen Smayra, Bernice L. Sim, et al. (+2) Azizullah Beran, Omar A. Danoun |
13 |
[GO] |
2021―Dec―23 |
The effects of lung involvement, clinical and laboratory parameters on outcome in elderly patients with coronavirus disease 2019 |
Ferda Bilgir, Şebnem Çalık, İsmail Demir, Özden Yıldırım Akan, Oktay Bilgir |
14 |
[GO] |
2021―Dec―04 |
Coronavirus disease 2019 in patients with chronic immune thrombocytopenia on thrombopoietin receptor agonists |
Nikola Pantic, Nada Suvajdzic-Vukovic, Marijana Virijevic, Zlatko Pravdic, Nikica Sabljic, Tatjana Adzic-Vukicevic, Mirjana Mitrovic |
15 |
[GO] |
2021―Oct―25 |
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury |
Luca Arcari, Michelangelo Luciani, Luca Cacciotti, Maria Beatrice Musumeci, Valerio Spuntarelli, Enrico Bentivegna, et al. (+6) Giovanni Camastra, Gerardo Ansalone, Claudio Santini, Paolo Martelletti, Massimo Volpe, Luciano De Biase |
16 |
[GO] |
2021―Oct―25 |
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura |
Kaitlyn C. Dykes, Craig M. Kessler |
17 |
[GO] |
2021―Sep―06 |
ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia |
Noppacharn Uaprasert, Krissana Panrong, Songphol Tungjitviboonkun, Kulwara Dussadee, Pakanat Decharatanachart, Peerapat Kaveevorayan, et al. (+4) Rossanun Shoosanglertwijit, Phandee Watanaboonyongcharoen, Udomsak Bunworasate, Ponlapat Rojnuckarin |
18 |
[GO] |
2021―Aug―09 |
Thrombogenicity markers for early diagnosis and prognosis in COVID-19 |
Paul A. Gurbel, Kevin P. Bliden, Jerrold H. Levy, Naval Walia, Nicole Rapista, Alastair Cho, et al. (+2) Christophe Jerjian, Udaya S. Tantry |
19 |
[GO] |
2021―Jul―29 |
Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings |
Nergiz Bayrakci, Gulsum Ozkan, Levent Cem Mutlu, lknur Erdem, Ilker Yildirim, Dumrul Gulen, Aliye Celikkol |
20 |
[GO] |
2021―Jul―26 |
A mild deficiency of ADAMTS13 is associated with severity in COVID-19 |
Reyes María Martín-Rojas, Maite Chasco-Ganuza, Sara Casanova-Prieto, Valeria Estefanía Delgado-Pinos, Gloria Pérez-Rus, Patricia Duque-González, et al. (+3) Milagros Sancho, José Luis Díez-Martín, Cristina Pascual-Izquierdo |
21 |
[GO] |
2021―May―19 |
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2 |
Matthias Karer, Karin Stiasny, Markus Zeitlinger, Bernd Jilma |
22 |
[GO] |
2021―Mar―20 |
Thrombohaemorhhagic balance in coronavirus disease 2019 and its management |
Kanjaksha Ghosh, Malay Ghosh |
23 |
[GO] |
2021―Feb―22 |
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019 |
Akbar Dorgalaleh, Shadi Tabibian, Mohammad Reza Baghaipour, Ali Dabbagh, Gholamreza Bahoush, Mohammad Jazebi, et al. (+3) Mehran Bahraini, Alieh Fazeli, Forough Yousefi |
24 |
[GO] |
2021―Jan―25 |
Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019 |
Patricia Duque, Maite Chasco-Ganuza, Alba Burgos-Santamaria, Estrella Terradillos |
25 |
[GO] |
2021―Jan―14 |
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection |
Joseph Bennett, Mark T. Cunningham, Christin Howard, Marc Hoffmann, Fred V. Plapp |
26 |
[GO] |
2021―Jan―14 |
Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU |
Raf De Jongh, Marisa Ninivaggi, Dieter Mesotten, Cui Bai, Berend Marcus, Dana Huskens, et al. (+6) Hendrik Stragier, Adam Miszta, Jasmine Verbruggen, Romy M.W. de Laat-Kremers, Jef Grieten, Bas de Laat |
27 |
[GO] |
2021―Jan―14 |
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia |
Raimondo De Cristofaro, Giovanna Liuzzo, Monica Sacco, Stefano Lancellotti, Daniela Pedicino, Felicita Andreotti |
28 |
[GO] |
2021―Jan―14 |
Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients |
Mansour Gergi, Andrew Goodwin, Kalev Freeman, Christos Colovos, Oksana Volod |
29 |
[GO] |
2021―Jan―13 |
Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors |
Maria-Teresa Calderon-Lopez, Natalia Garcia-Leon, Sergio Gomez-Arevalillo, Purificacion Martin-Serrano, Arturo Matilla-Garcia |
30 |
[GO] |
2020―Dec―03 |
Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit |
Amer Hamadé, Bastien Woehl, Ines Harzallah, Marjolaine Talbot, Jonathan Tousch, Lucas Jambert |
31 |
[GO] |
2020―Nov―17 |
Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019 |
Rohit S. Loomba, Gaurav Aggarwal, Enrique G. Villarreal, Juan S. Farias, Saul Flores, Carl J. Lavie, Saurabh Aggarwal |
32 |
[GO] |
2020―Nov―17 |
Derangement of the coagulation process using subclinical markers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneumonia |
Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Andrew Horton, Lorenzo R. Suardi |
33 |
[GO] |
2020―Nov―11 |
The association of oxygen saturation, tomography findings and d-dimer levels in coronavirus disease 2019 patients |
Kadir S. Yalçin, Benan Kasapoğlu, Recep Alanli, Murat B. Küçükay, Ali Koşar |
34 |
[GO] |
2020―Sep―06 |
Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children |
Hyppolite Kuekou Tchidjou, Fiorella Caron, Adeline Ferec, Karine Braun, Loic Hery, Sandrine Castelain, Bernard Romeo |
35 |
[GO] |
2020―Jul―02 |
D-Dimer serum levels as a biomarker associated for the lethality in patients with coronavirus disease 2019 |
William G. Lima, Ayslan Barra, Júlio César M. Brito, Waleska S.C. Nizer |